Logo image of ACT.DE

ALZCHEM GROUP AG (ACT.DE) Stock Fundamental Analysis

Europe - FRA:ACT - DE000A2YNT30 - Common Stock

156.6 EUR
-3.2 (-2%)
Last: 10/10/2025, 7:00:00 PM
Fundamental Rating

7

ACT gets a fundamental rating of 7 out of 10. The analysis compared the fundamentals against 71 industry peers in the Chemicals industry. ACT gets an excellent profitability rating and is at the same time showing great financial health properties. ACT is valied quite expensively at the moment, while it does show a decent growth rate. With these ratings, ACT could be worth investigating further for quality investing!.


Dividend Valuation Growth Profitability Health

9

1. Profitability

1.1 Basic Checks

ACT had positive earnings in the past year.
ACT had a positive operating cash flow in the past year.
In the past 5 years ACT has always been profitable.
ACT had a positive operating cash flow in 4 of the past 5 years.
ACT.DE Yearly Net Income VS EBIT VS OCF VS FCFACT.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M 60M 80M 100M

1.2 Ratios

With an excellent Return On Assets value of 10.48%, ACT belongs to the best of the industry, outperforming 94.37% of the companies in the same industry.
With an excellent Return On Equity value of 26.66%, ACT belongs to the best of the industry, outperforming 98.59% of the companies in the same industry.
The Return On Invested Capital of ACT (13.72%) is better than 94.37% of its industry peers.
ACT had an Average Return On Invested Capital over the past 3 years of 12.06%. This is significantly above the industry average of 6.85%.
The 3 year average ROIC (12.06%) for ACT is below the current ROIC(13.72%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 10.48%
ROE 26.66%
ROIC 13.72%
ROA(3y)8.81%
ROA(5y)7.86%
ROE(3y)22.87%
ROE(5y)25.91%
ROIC(3y)12.06%
ROIC(5y)10.63%
ACT.DE Yearly ROA, ROE, ROICACT.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

1.3 Margins

ACT's Profit Margin of 10.43% is amongst the best of the industry. ACT outperforms 80.28% of its industry peers.
In the last couple of years the Profit Margin of ACT has grown nicely.
ACT's Operating Margin of 15.34% is amongst the best of the industry. ACT outperforms 83.10% of its industry peers.
In the last couple of years the Operating Margin of ACT has grown nicely.
ACT's Gross Margin of 65.74% is amongst the best of the industry. ACT outperforms 97.18% of its industry peers.
In the last couple of years the Gross Margin of ACT has remained more or less at the same level.
Industry RankSector Rank
OM 15.34%
PM (TTM) 10.43%
GM 65.74%
OM growth 3Y17.53%
OM growth 5Y12.4%
PM growth 3Y14.29%
PM growth 5Y15.31%
GM growth 3Y2.01%
GM growth 5Y1.44%
ACT.DE Yearly Profit, Operating, Gross MarginsACT.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

9

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), ACT is creating value.
ACT has less shares outstanding than it did 1 year ago.
The number of shares outstanding for ACT has been reduced compared to 5 years ago.
The debt/assets ratio for ACT has been reduced compared to a year ago.
ACT.DE Yearly Shares OutstandingACT.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M
ACT.DE Yearly Total Debt VS Total AssetsACT.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

2.2 Solvency

An Altman-Z score of 5.12 indicates that ACT is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 5.12, ACT belongs to the top of the industry, outperforming 91.55% of the companies in the same industry.
The Debt to FCF ratio of ACT is 1.15, which is an excellent value as it means it would take ACT, only 1.15 years of fcf income to pay off all of its debts.
ACT has a Debt to FCF ratio of 1.15. This is amongst the best in the industry. ACT outperforms 95.77% of its industry peers.
ACT has a Debt/Equity ratio of 0.18. This is a healthy value indicating a solid balance between debt and equity.
ACT's Debt to Equity ratio of 0.18 is fine compared to the rest of the industry. ACT outperforms 73.24% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.18
Debt/FCF 1.15
Altman-Z 5.12
ROIC/WACC1.92
WACC7.16%
ACT.DE Yearly LT Debt VS Equity VS FCFACT.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M 200M

2.3 Liquidity

A Current Ratio of 2.84 indicates that ACT has no problem at all paying its short term obligations.
The Current ratio of ACT (2.84) is better than 83.10% of its industry peers.
ACT has a Quick Ratio of 1.73. This is a normal value and indicates that ACT is financially healthy and should not expect problems in meeting its short term obligations.
With a decent Quick ratio value of 1.73, ACT is doing good in the industry, outperforming 78.87% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.84
Quick Ratio 1.73
ACT.DE Yearly Current Assets VS Current LiabilitesACT.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

6

3. Growth

3.1 Past

ACT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 25.65%, which is quite impressive.
The Earnings Per Share has been growing by 24.60% on average over the past years. This is a very strong growth
Looking at the last year, ACT shows a small growth in Revenue. The Revenue has grown by 1.03% in the last year.
ACT shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 8.06% yearly.
EPS 1Y (TTM)25.65%
EPS 3Y25.02%
EPS 5Y24.6%
EPS Q2Q%10.81%
Revenue 1Y (TTM)1.03%
Revenue growth 3Y9.49%
Revenue growth 5Y8.06%
Sales Q2Q%4.91%

3.2 Future

ACT is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 19.37% yearly.
The Revenue is expected to grow by 6.02% on average over the next years.
EPS Next Y17.45%
EPS Next 2Y16.02%
EPS Next 3Y19.32%
EPS Next 5Y19.37%
Revenue Next Year2.89%
Revenue Next 2Y6.03%
Revenue Next 3Y8.49%
Revenue Next 5Y6.02%

3.3 Evolution

Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
ACT.DE Yearly Revenue VS EstimatesACT.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 200M 400M 600M 800M
ACT.DE Yearly EPS VS EstimatesACT.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2 4 6 8 10

3

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 27.43, the valuation of ACT can be described as expensive.
Compared to the rest of the industry, the Price/Earnings ratio of ACT is on the same level as its industry peers.
The average S&P500 Price/Earnings ratio is at 27.02. ACT is around the same levels.
A Price/Forward Earnings ratio of 22.84 indicates a rather expensive valuation of ACT.
Compared to the rest of the industry, the Price/Forward Earnings ratio of ACT is on the same level as its industry peers.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.57, ACT is valued at the same level.
Industry RankSector Rank
PE 27.43
Fwd PE 22.84
ACT.DE Price Earnings VS Forward Price EarningsACT.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as ACT.
The rest of the industry has a similar Price/Free Cash Flow ratio as ACT.
Industry RankSector Rank
P/FCF 38.54
EV/EBITDA 14.44
ACT.DE Per share dataACT.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40 50

4.3 Compensation for Growth

The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
The excellent profitability rating of ACT may justify a higher PE ratio.
ACT's earnings are expected to grow with 19.32% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.57
PEG (5Y)1.12
EPS Next 2Y16.02%
EPS Next 3Y19.32%

4

5. Dividend

5.1 Amount

ACT has a Yearly Dividend Yield of 1.21%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 3.05, ACT is paying slightly less dividend.
Compared to an average S&P500 Dividend Yield of 2.44, ACT's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 1.21%

5.2 History

The dividend of ACT has a limited annual growth rate of 6.00%.
Dividend Growth(5Y)6%
Div Incr Years5
Div Non Decr Years5
ACT.DE Yearly Dividends per shareACT.DE Yearly Dividends per shareYearly Dividends per share 2020 2021 2022 2023 2024 2025 0.5 1 1.5

5.3 Sustainability

ACT pays out 31.40% of its income as dividend. This is a sustainable payout ratio.
ACT's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP31.4%
EPS Next 2Y16.02%
EPS Next 3Y19.32%
ACT.DE Yearly Income VS Free CF VS DividendACT.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M 60M
ACT.DE Dividend Payout.ACT.DE Dividend Payout, showing the Payout Ratio.ACT.DE Dividend Payout.PayoutRetained Earnings

ALZCHEM GROUP AG

FRA:ACT (10/10/2025, 7:00:00 PM)

156.6

-3.2 (-2%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)07-30 2025-07-30
Earnings (Next)10-30 2025-10-30
Inst Owners35.95%
Inst Owner ChangeN/A
Ins Owners30.48%
Ins Owner ChangeN/A
Market Cap1.59B
Analysts81.82
Price Target161.52 (3.14%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.21%
Yearly Dividend1.2
Dividend Growth(5Y)6%
DP31.4%
Div Incr Years5
Div Non Decr Years5
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)12.29%
PT rev (3m)33.25%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0.59%
EPS NY rev (3m)2.73%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.06%
Revenue NY rev (3m)-0.66%
Valuation
Industry RankSector Rank
PE 27.43
Fwd PE 22.84
P/S 2.87
P/FCF 38.54
P/OCF 14.16
P/B 7.34
P/tB 7.46
EV/EBITDA 14.44
EPS(TTM)5.71
EY3.65%
EPS(NY)6.86
Fwd EY4.38%
FCF(TTM)4.06
FCFY2.59%
OCF(TTM)11.06
OCFY7.06%
SpS54.57
BVpS21.35
TBVpS20.99
PEG (NY)1.57
PEG (5Y)1.12
Profitability
Industry RankSector Rank
ROA 10.48%
ROE 26.66%
ROCE 19.03%
ROIC 13.72%
ROICexc 16.02%
ROICexgc 16.17%
OM 15.34%
PM (TTM) 10.43%
GM 65.74%
FCFM 7.45%
ROA(3y)8.81%
ROA(5y)7.86%
ROE(3y)22.87%
ROE(5y)25.91%
ROIC(3y)12.06%
ROIC(5y)10.63%
ROICexc(3y)13.35%
ROICexc(5y)11.55%
ROICexgc(3y)13.5%
ROICexgc(5y)11.66%
ROCE(3y)16.73%
ROCE(5y)14.74%
ROICexcg growth 3Y25.57%
ROICexcg growth 5Y18.04%
ROICexc growth 3Y25.41%
ROICexc growth 5Y17.9%
OM growth 3Y17.53%
OM growth 5Y12.4%
PM growth 3Y14.29%
PM growth 5Y15.31%
GM growth 3Y2.01%
GM growth 5Y1.44%
F-Score7
Asset Turnover1
Health
Industry RankSector Rank
Debt/Equity 0.18
Debt/FCF 1.15
Debt/EBITDA 0.36
Cap/Depr 270.53%
Cap/Sales 12.82%
Interest Coverage 42.05
Cash Conversion 100.91%
Profit Quality 71.41%
Current Ratio 2.84
Quick Ratio 1.73
Altman-Z 5.12
F-Score7
WACC7.16%
ROIC/WACC1.92
Cap/Depr(3y)118.98%
Cap/Depr(5y)119.68%
Cap/Sales(3y)5.65%
Cap/Sales(5y)6.26%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)25.65%
EPS 3Y25.02%
EPS 5Y24.6%
EPS Q2Q%10.81%
EPS Next Y17.45%
EPS Next 2Y16.02%
EPS Next 3Y19.32%
EPS Next 5Y19.37%
Revenue 1Y (TTM)1.03%
Revenue growth 3Y9.49%
Revenue growth 5Y8.06%
Sales Q2Q%4.91%
Revenue Next Year2.89%
Revenue Next 2Y6.03%
Revenue Next 3Y8.49%
Revenue Next 5Y6.02%
EBIT growth 1Y19.3%
EBIT growth 3Y28.68%
EBIT growth 5Y21.47%
EBIT Next Year49.4%
EBIT Next 3Y27.83%
EBIT Next 5Y19.11%
FCF growth 1Y37.04%
FCF growth 3Y62.42%
FCF growth 5Y94.14%
OCF growth 1Y113.41%
OCF growth 3Y34.7%
OCF growth 5Y19.23%